Andrew Gengos, See Below at Athira Pharma, Inc. (ATHA), sold 1,208 shares at $2.91 ($4K) on 2023-01-05, disclosed to the SEC on 2024-01-08.
Open-market sale of $4k ATHA by See Below. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATHA | SELL | 2024-09-05 | $725 | — | Filing → |
| ATHA | SELL | 2024-02-16 | $4K | — | Filing → |
| ATHA | BUY | 2023-06-09 | $51K | — | Filing → |